These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25158212)

  • 1. Different effects of tacrolimus and cyclosporine on PDGF induction and chronic allograft injury: evidence for improved kidney graft outcome.
    Savikko J; Teppo AM; Taskinen E; von Willebrand E
    Transpl Immunol; 2014 Sep; 31(3):145-51. PubMed ID: 25158212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of FK778 on acute rat renal allograft rejection and expression of platelet-derived growth factor and transforming growth factor-beta.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Oct; 38(8):2719-21. PubMed ID: 17098049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of acute rejection and cyclosporin A-treatment on induction of platelet-derived growth factor and its receptors during the development of chronic rat renal allograft rejection.
    Savikko J; Kallio EA; Taskinen E; von Willebrand E
    Transplantation; 2002 Feb; 73(4):506-11. PubMed ID: 11889420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early induction of platelet-derived growth factor ligands and receptors in acute rat renal allograft rejection.
    Savikko J; Kallio EA; von Willebrand E
    Transplantation; 2001 Jul; 72(1):31-7. PubMed ID: 11468531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and structural consequences of early renal allograft injury.
    Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
    Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy.
    Savikko J; Taskinen E; Von Willebrand E
    Transplantation; 2003 Apr; 75(8):1147-53. PubMed ID: 12717194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early short-term platelet-derived growth factor inhibition prevents the development of chronic allograft nephropathy in experimental rat kidney transplantation.
    Savikko J; Rintala J; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3231-2. PubMed ID: 17175231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity.
    Khanna A; Plummer M; Bromberek C; Bresnahan B; Hariharan S
    Kidney Int; 2002 Dec; 62(6):2257-63. PubMed ID: 12427154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching from cyclosporine to tacrolimus in patients with chronic transplant dysfunction or cyclosporine-induced adverse events.
    Cantarovich D; Renou M; Megnigbeto A; Giral-Classe M; Hourmant M; Dantal J; Blancho G; Karam G; Soulillou JP
    Transplantation; 2005 Jan; 79(1):72-8. PubMed ID: 15714172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do drug transporter (ABCB1) SNPs influence cyclosporine and tacrolimus dose requirements and renal allograft outcome in the posttransplantation period?
    Singh R; Srivastava A; Kapoor R; Mittal RD
    J Clin Pharmacol; 2011 Apr; 51(4):603-15. PubMed ID: 20571034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Platelet-Derived Growth Factor and Vascular Endothelial Growth Factor Inhibitor Sunitinib Prevents Chronic Allograft Injury in Experimental Kidney Transplantation Model.
    Rintala JM; Savikko J; Palin N; Rintala SE; Koskinen PK; von Willebrand E
    Transplantation; 2016 Jan; 100(1):103-10. PubMed ID: 26262503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor (VEGF) ligand and receptor induction in rat renal allograft rejection.
    Rintala SE; Savikko J; Rintala JM; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3236-8. PubMed ID: 17175233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
    Nankivell BJ; PʼNg CH; OʼConnell PJ; Chapman JR
    Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.
    Koziolek MJ; Riess R; Geiger H; Thévenod F; Hauser IA
    Kidney Int; 2001 Jul; 60(1):156-66. PubMed ID: 11422747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
    Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.
    Koskinen PK; Lemström KB; Häyry PJ
    Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial.
    Plischke M; Riegersperger M; Dunkler D; Heinze G; Kikić Ž; Winkelmayer WC; Sunder-Plassmann G
    PLoS One; 2015; 10(8):e0135674. PubMed ID: 26270340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.